SANA
NASDAQ · Biotechnology
Sana Biotechnology Inc
$3.27
-0.02 (-0.61%)
Financial Highlights (FY 2025)
Revenue
204.77M
Net Income
17.06M
Gross Margin
30.1%
Profit Margin
8.3%
Rev Growth
+11.7%
D/E Ratio
0.32
Revenue & Net Income
Margin Trends
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Gross Margin | 30.1% | 30.1% | 30.1% |
| Operating Margin | 9.1% | 10.6% | 10.8% |
| Profit Margin | 8.3% | 7.9% | 7.9% |
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 204.77M | 187.81M | 190.12M |
| Gross Profit | 61.61M | 56.50M | 57.20M |
| Operating Income | 18.60M | 19.90M | 20.52M |
| Net Income | 17.06M | 14.80M | 14.99M |
| Gross Margin | 30.1% | 30.1% | 30.1% |
| Operating Margin | 9.1% | 10.6% | 10.8% |
| Profit Margin | 8.3% | 7.9% | 7.9% |
| Rev Growth | +11.7% | +19.4% | -6.7% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 155.46M | 154.98M | 147.10M |
| Total Equity | 484.95M | 579.60M | 502.47M |
| D/E Ratio | 0.32 | 0.27 | 0.29 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 24.96M | 25.10M | 25.01M |
| Free Cash Flow | 20.72M | 16.56M | 17.82M |